Image of CERTs Logo
clearpixel.gif

About CERTs

Annual Report Year 6

AHRQ Letter | Steering Committee Letter | Introduction | CERTs Progress | Certs Program Resources | Certs Parnerships and Collaborations | Conclusion | The CERTs Organization | Principles of CERTs Public-Private Partnerships | Peer-Reviewed Publications


Peer-Reviewed Publications

Referenced Publications

  • Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005;141:1132-1136.
  • Aberra FN, Brensinger CM, Bilker WB, Lichtenstein GR, Lewis JD. Antibiotic use and the risk of flare of inflammatory bowel disease. Clin Gastroenterol Hepatol 2005;3:459-465.
  • Levy RM, Leyden JJ, Margolis DJ. Colonisation rates of Streptococcus pyogenes and Staphylococcus aureus in the oropharynx of a young adult population. Clin Microbiol Infect 2005;11:153-155.
  • Long CB, Shah SS, Lautenbach E, Coffin SE, Tabbutt S, Gaynor JW, Bell LM. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J 2005;24:315-319.
  • Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf 2006;15:361-368.
  • Harrold LR, Andrade SE, Eisner M, Buist AS, Go A, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Davis KJ, Platt R. Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf 2004;13:661- 667.
  • Fessler BJ, Alarcon GS, McGwin G, Jr., Roseman J, Bastian HM, Friedman AW, Baethge BA, Vila L, Reveille JD. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 2005;52:1473-1480.
  • Al Khatib SM, Allen LaPointe NM, Kramer JM, Chen AY, Hammill BG, Delong L, Califf RM. A survey of health care practitioners' knowledge of the QT interval. J Gen Intern Med 2005;20:392-396.
  • Abraham NS, El Serag HB, Johnson ML, Hartman C, Richardson P, Ray WA, Smalley W. National adherence to evidence-based guidelines the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 2005;129:1171-1178.
  • Lo Re V, Gasink L, Kostman JR, Leonard D, Gross R. Natural history of patients with low-level HIV viremia on antiretroviral therapy. AIDS Patient Care STDS 2004;18:436-442.
  • Hulgan T, Sterling TR, Daugherty J, Arbogast PG, Raffanti S, Ray W. Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons. J Acquir Immune Defic Syndr 2005;38:277-282.
  • Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004;57:1107- 1110.
  • Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005;14:789-793.
  • Mikuls TR, Saag KG, George V, Mudano AS, Banerjee S. Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture. J Rheumatol 2005;32:870-875.
  • Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 2005;52:2485-2494.
  • Hicks RW, Becker SC, Cousins DD. Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX program. J Pediatr Nurs 2006;21:290-298.
  • Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm. 2005;62:1983-1991.
  • Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health Syst Pharm 2004;61:1484- 1487.
  • Wegner S, Vann JJ, Liu G, Byrns P, Cypra C, Campbell W, Stiles A. Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program. Pediatrics 2004;114:1612- 1619.
  • Cowper PA, Udayakumar K, Sketch MH, Jr., Peterson ED. Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention. J Am Coll Cardiol 2005;45:369-376.
  • Pisu M, James N, Sampsel S, Saag KG. The cost of glucocorticoid- associated adverse events in rheumatoid arthritis. Rheumatology (Oxford) 2005;44:781-788.
  • Cooper WO, Arbogast PG, Hickson GB, Daugherty JR, Ray WA. Gaps in enrollment from a Medicaid managed care program: effects on emergency department visits and hospitalizations for children with asthma. Med Care 2005;43:718-725.
  • M'ikanatha NM, Julian KG, Kunselman AR, Aber RC, Rankin JT, Lautenbach E. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak. BMC Public Health 2005;5:2.

To Top